NCT00156910已完成3 期
A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 679
- 试验地点
- 2
- 主要终点
- Change in Frequency of Headache Episodes
研究概览
简要总结
This is a 60 week study including a double-blind phase followed by an open-label extension phase.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Frequent migraine (>=15 headache days per month)
- •>=4 distinct headache episodes lasting >=4 hours
- •>=50% of baseline headache days migraine/probable migraine days
排除标准
- •Previous use of botulinum toxin of any serotype or immunization to any botulinum toxin serotype
- •Any medical condition that puts the patient at increased risk with exposure to BOTOX
- •Diagnosis of complicated migraine, chronic tension-type headache, hypnic headache, hemicrania continua, new daily persistent headache
- •Use of prophylactic headache medication within 28 days prior to week -4
- •Unremitting headache lasting continuously throughout the 4-week baseline period
- •Known or suspected Temporomandibular Disorders (TMD)
- •Diagnosis of fibromyalgia
- •Beck depression inventory score >24 at week-4
- •Psychiatric problems that may have interfered with study participation
结局指标
主要结局
Change in Frequency of Headache Episodes
时间窗: Baseline, Week 24
Mean change from baseline in frequency (number) of headache episodes during the 28 day period ending with Week 24. Headache episode defined as patient-reported headache with a start and stop time indicating that the pain lasted \>= 4 continuous hours.
次要结局
- Change in Frequency of Headache Days(Baseline, Week 24)
- Change in Frequency of Acute Headache Pain Medication Intakes(Baseline, Week 24)
- Change in Frequency of Migraine/Probable Migraine Headache Days(Baseline, Week 24)
- Change in Frequency of Migraine/Probable Migraine Headache Episodes(Baseline, Week 24)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent HeadachesMigraine DisordersNCT00168428Allergan705
已完成
2 期
A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic NeuralgiaPostherpetic NeuralgiaNCT00168441Allergan117
已完成
3 期
Dysport® In Migraine Without Aura Prophylaxis : DIMWAP StudyMigraine Without Aura ProphylaxisNCT00258609Department of Medical Services Ministry of Public Health of Thailand128
已完成
不适用
A Pilot Study of the Effect of Botulinum Toxin Type a (Dysport®, Abobotulinum Toxin A) Injection on Changes in Musculotendinous Length and Dynamics of Hamstring Muscles During Gait in Children With Spastic Cerebral Palsy Walking With Excessive Knee FlexionCerebral PalsyNCT02917967Yonsei University31
已完成
2 期
The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia UniversalisRecalcitrant Alopecia TotalisRecalcitrant Alopecia UniversalisNCT00997815Siriraj Hospital20